Trans Genic Inc (2342) to Release Q3 2008 Earnings February 15

Trans Genic Inc (TYO3:2342) will release the third quarter earnings for February 15.

Headquartered in Kumamoto, Japan, Trans Genic engages in the biotechnology business.  The company is organized into three business segments, Gene Knockout Mouse, Atnibody and Others.

The Gene Knockout Mouse segment engages in the licensing of gene knockout mice related information and experimental animal related entrusted business which includes the fabrication and the analysis of gene modified mice.

The Antibody segment develops, produces and sells antibody products, the licensing to produce technology for high affinity antibodies and entrusts businesses related to antibodies and proteins.

The Others segment is engaged in the entrusted rearing management business, the development and sale of reagents based on protein production and refining technology for bio tests.  This segment also provides reproduction technology education and environmental risk related services.

For more Earnings related events or to post your own events, visit
http://events.finditt.com/Events_list.aspx?catid=13